TABLE 4.
BYHW (n = 34) | Control (n = 33) | p value | |
---|---|---|---|
ADP/ATP Ratio | |||
Before treatment | 1.43 ± 2.80 | 1.00 ± 0.69 | 0.395 |
After treatment | 0.76 ± 0.47* | 0.80 ± 0.76 | 0.796 |
GLU (mmol/L) | |||
Before treatment | 7.99 ± 4.00 | 6.40 ± 2.12 | 0.046 |
After treatment | 6.42 ± 1.90** | 5.46 ± 1.79** | 0.039 |
TC (mmol/L) | |||
Before treatment | 4.01 ± 1.06 | 4.34 ± 1.21 | 0.24 |
After treatment | 3.55 ± 0.81* | 3.98 ± 0.92 | 0.05 |
TG (mmol/L) | |||
Before treatment | 1.66 ± 1.20 | 1.70 ± 0.92 | 0.891 |
After treatment | 1.51 ± 0.63 | 1.76 ± 1.22 | 0.294 |
HDL-C (mmol/L) | |||
Before treatment | 1.18 ± 0.29 | 1.11 ± 0.21 | 0.264 |
After treatment | 1.29 ± 0.29 | 1.20 ± 0.22 | 0.128 |
LDL-C (mmol/L) | |||
Before treatment | 2.50 ± 0.75 | 2.57 ± 0.91 | 0.74 |
After treatment | 2.09 ± 0.68** | 2.42 ± 0.73 | 0.064 |
ADP, adenosine diphosphate; ATP, adenosine triphosphate; GLU, glucose; TC, total cholesterol; TG, triglyceride; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol, *p < 0.05, **p < 0.01.